Research From UB Department Of Social And Preventive Medicine Takes Center Stage In American Journal Of Epidemiology

December 02, 1997

BUFFALO, N.Y. -- The Department of Social and Preventive Medicine at the University at Buffalo has trained some of the most respected epidemiologists in the U.S. and produced significant and innovative research in cancer, occupational, environmental, nutritional, reproductive and cardiovascular epidemiology.

In recognition of its contributions to the field, the Dec. 2 issue of the American Journal of Epidemiology is dedicated to research by faculty members and graduates of the UB Department of Social and Preventive Medicine.

"The publication of this issue celebrates the rich legacy of the department and the UB School of Medicine and Biomedical Sciences," said Maurizio Trevisan, M.D., professor and chair of the department. "It affirms the important contribution that our training programs have made to the field of epidemiology and prevention."

Saxon Graham, Ph.D., one of the pioneers in the study of the relationship of diet and disease, spent his career at the University at Buffalo, where he conducted some of the earliest studies in the U.S. on the health benefits of a diet high in vegetables containing beta carotene, now shown to lower the risk of certain cancers.

Jo L. Freudenheim, Ph.D., associate professor, has continued that research, and in the past decade has earned a reputation as one of the nation's leading nutritional epidemiologists.

Other departmental research highlights include:The issue's lead article, "Body Mass Index and Mortality in a General Population Sample of Men and Women," authored by Joan M. Dorn, Ph.D., assistant professor, reports that being overweight is a significant mortality risk factor for women and men less than 65 years old.

Other articles (news releases are attached) and lead authors include:The issue begins with historical overviews of the UB medical school -- which marked its sesquicentennial in 1996 -- the department and epidemiology in Western New York, dating back to 1843. Graduate Philip C. Nasca, Ph.D., professor of epidemiology at the University of Massachusetts, Amherst, writes on current problems and future opportunities in the field and graduate Christine B. Ambrosone, Ph.D., discusses the new field of molecular epidemiology.

The final two studies concern the reliability of study participants' reports of lifetime drinking history (by Marcia Russell, UB clinical professor) and of reports of pap smears, breast exams and mammograms (by Richard B. Warnecke, Ph.D., formerly of UB, now of the University of Illinois at Chicago).

Graduates of the department include top officials and/or researchers at the National Cancer Institute, Monsanto Co., the National Center for Toxicological Research, New York State Department of Health, Roswell Park Cancer Institute, Centers for Disease Control and Prevention, Illinois Department of Public Health, University of Massachusetts at Amherst, University of Iowa and Northern California Cancer Center.

University at Buffalo

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to